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Deletion of self-antigen-specific T cells during thymic
development provides protection from autoimmu-
nity. However, it is unclear how efficiently this occurs
for tissue-restricted self antigens, or how immune
tolerance is maintained for self-antigen-specific
T cells that routinely escape deletion. Here we
show that endogenous CD4+ T cells with specificity
for a set of tissue-restricted self antigens were not
deleted at all. For pancreatic self antigen, this re-
sulted in an absence of steady-state tolerance, while
for the lung and intestine, tolerance was maintained
by the enhanced presence of thymically-derived an-
tigen-specific Foxp3+ regulatory T (Treg) cells. Unlike
deletional tolerance, Treg cell-mediated tolerance
was broken by successive antigen challenges. These
findings reveal that for some tissue-restricted self
antigens, tolerance relies entirely on nondeletional
mechanisms that are less durable than T cell dele-
tion. This might explain why autoimmunity is often
tissue-specific, and it offers a rationale for cancer
vaccine strategies targeting tissue-restricted tumor
antigens.
INTRODUCTION
To enable recognition of virtually any pathogen, the adaptive im-
mune system harbors a vast diversity of T cell clones, each with a
unique T cell antigen receptor (TCR) that is randomly generated
during development in the thymus. To prevent autoimmunity,
T cell clones with high TCR reactivity to self antigens presented
in the thymus are deleted through negative selection, leaving
behind a peripheral repertoire of mature T cells that is largely896 Immunity 43, 896–908, November 17, 2015 ª2015 Elsevier Inc.foreign antigen specific (Hogquist et al., 2005). This basic model
of central tolerance applies not only to ubiquitous self antigens,
but also to ‘‘tissue-restricted’’ self antigens that are normally
absent from the thymus. This is possible due to broad patterns
of antigen presentation by the panoply of specialized antigen-
presenting cell types found in the thymus (Klein et al., 2009),
including medullary thymic epithelial cells that express tissue-
restricted genes promiscuously through the activity of the tran-
scriptional regulator Aire (Mathis and Benoist, 2009).
Despite the efficiency of thymic selection and the fact that
some self antigen-specific T cells are also deleted in the periph-
ery (Metzger and Anderson, 2011; Redmond and Sherman,
2005), the mature peripheral T cell repertoire is known to harbor
significant self antigen specificity (Hogquist and Jameson, 2014),
a point made clear by numerous experimental models of autoim-
munity that are induced by immunization with self antigens.
However, the extent to which central tolerance fails and self-
antigen-specific T cells escape deletion is unclear, particularly
in the case of tissue-restricted self antigens.
The identity of self-antigen-specific T cells in the peripheral
repertoire is of paramount importance, because these cells are
likely involved in autoimmunity as well as anti-tumor immunity.
Some of these cells might simply be ignorant of self antigens
that are rare or poorly sampled by dendritic cells. Alternatively,
these cells might exist in a hyporesponsive state of anergy, the
induction of which can constitute a nondeletional mechanism
of tolerance (Choi and Schwartz, 2007). In the case of CD4+
T cells, many self-antigen-specific T cells are thought to be reg-
ulatory T (Treg) cells that suppress rather than promote immunity
(Sakaguchi et al., 2008). While some Treg cells differentiate from
conventional CD4+ T cells (Tconv) in the periphery, most are
generated in the thymus through TCR recognition of self antigens
in a process that diverges from negative selection (Josefowicz
et al., 2012). Comprehensive analyses of TCR repertoires have
shown that the specificities of CD4+ Treg and Tconv cell subsets
exhibit limited overlap, suggesting that Treg cell specificity is
biased toward self antigens (Hsieh et al., 2012).
Our understanding of self-antigen specificity within the T cell
repertoire has been hampered by the technical challenges of
studying self-antigen-specific T cells. The frequency of T cells
with specificity to any single foreign peptide:MHC epitope is
extremely small, estimated in the range of 1 to 100 per million
CD8+ T cells, or 0.1 to 10 per million CD4+ T cells (Jenkins and
Moon, 2012). In the case of self-antigen-specific T cells, which
are presumably impacted by deletional tolerance, these fre-
quencies might be even lower. Hence, most studies of self-anti-
gen-specific T cells have involved the use of TCR transgenic
mice crossed with mice expressing the cognate antigen (Hog-
quist et al., 2005; Wirnsberger et al., 2011). While such studies
have provided important insights into various mechanisms
of T cell tolerance to self antigens, it is now clear that in vivo
systems involving abnormally high frequencies of monoclonal
T cells often fail to accurately model the development of self-
antigen-specific T cells (Bautista et al., 2009; Leung et al.,
2009). To overcome these limitations, we have developed pepti-
de:MHCII tetramer-based cell enrichment techniques to enable
direct characterization of self-antigen-specific CD4+ T cells
within completely unmanipulated endogenous T cell repertoires
(Moon et al., 2007, 2011). Using this approach, we previously re-
vealed that a significant proportion of a CD4+ T cell population
specific for a ubiquitous self antigen survives deletion, which
raised the question of how efficiently T cell tolerance is estab-
lished to self antigens with more limited patterns of expression.
In this study, we created an experimental system in which a
model self antigen was expressed in mice through different
tissue-specific promoters and the development of the same
endogenous antigen-specific CD4+ T cell population was
compared across each of these strains. This enabled us to
isolate the effects of self-antigen tissue localization on CD4+
T cell deletion and Treg cell development in a highly controlled,
extremely physiological in vivo context. We found that tissue-
restricted expression of this self antigenwasmet with a profound
lack of antigen-specific T cell deletion, which depending on
the tissue site of expression resulted in either an absence of
steady-state tolerance or tolerance maintained by antigen-spe-
cific Treg cells.
RESULTS
Absence of Deletional T Cell Tolerance to Tissue-
Restricted Self Antigens
To investigate how T cell tolerance to a self antigen is affected by
the tissue environment in which it is expressed, we modeled Cre
recombinase as a neo self antigen. Cre is a Bacteriophage P1
protein that is normally absent in laboratory mice (Kasman,
2005) and can thus serve as a tissue-restricted self antigen
in various Cre transgenic mouse strains. RIP-Cre (rat insulin
promoter), CC10-Cre (Clara cell specific promoter), and Vil-Cre
(villin promoter) transgenic mice were used tomodel self-antigen
expression in pancreatic b islets, lung epithelium, and intestinal
epithelium, respectively, while UBC-CreER transgenic mice
served as controls for ubiquitous self-antigen expression. Quan-
titative RT-PCR analysis confirmed tissue-restricted expression
patterns of Cre mRNA in these mice (Figure 1A).
We mapped an immunogenic I-Ab-restricted epitope corre-
sponding to residues 61-71 of Cre which is recognized by aIrelatively large frequency of naive CD4+ T cells in C57BL/6 mice
(Figures S1A–S1D), and used this for our analysis of Cre:I-Ab-
specific T cells throughout our study. Background levels of
Cre:I-Ab tetramer staining were assessed by internal CD8+
T cell staining controls aswell as two-color double tetramer stain-
ing experiments (Figures S1E and S1F).
Cre:I-Ab tetramer-based magnetic cell enrichment was
used to directly measure total numbers of rare endogenous
Cre:I-Ab-specific CD4+ T cells in wild-type (WT) and Cre trans-
genic mice. Naive WT mice, in which Cre is a foreign antigen,
contained endogenous populations of 165 Cre:I-Ab-specific
CD4+ single positive thymocytes in the thymus (Figures 1B and
1D), and 185 Cre:I-Ab-specific mature CD4+ T cells in the
peripheral lymphoid organs (Figures 1C and 1E). UBC-CreER
mice contained 60% fewer Cre:I-Ab-specific cells in both the
thymus and periphery, indicating efficient thymic negative selec-
tion of T cells specific for ubiquitously expressed Cre self
antigen. However, Cre:I-Ab-specific T cell numbers were not
lower in the thymus or periphery of any other Cre transgenic
mouse, indicating a marked absence of deletional T cell toler-
ance against Cre self antigen when expression was restricted
to the pancreas, lung, or intestine.
To determine whether Cre:I-Ab self antigen presentation from
these tissues was sufficient for T cell recognition, CFSE dye
labeled Cre:I-Ab-specific T cells from Cre immunized WT mice
were adoptively transferred into WT or Cre mice and monitored
for cell division as an indication of antigen-induced activation
(Figure S1G). Transferred cells divided in CC10-Cre, Vil-Cre,
andUBC-CreERmice, but only showedminimal signs of division
in RIP-Cre mice, indicating efficient presentation of Cre:I-Ab
complexes from Cre-expressing lung and intestinal tissues, but
only poor presentation from pancreatic tissues.
Nondeletional T Cell Tolerance to Lung and Intestinal
Tissue-Restricted Self Antigens
Cre:I-Ab-specific T cells in Cre transgenic mice generally ex-
pressed low levels of CD44 that was consistent with a naive
phenotype (Figures 1B and 1C), and we did not observe obvious
phenotypic markers that distinguished them from their counter-
parts in WT mice (data not shown). To test the function of these
T cells, we subcutaneously immunized each of the Cre trans-
genic strains with Cre peptide emulsified in complete Freund’s
adjuvant (CFA) and measured their proliferative response
7 days later. As expected, Cre:I-Ab-specific T cells expanded
robustly in WT mice and poorly in UBC-CreER mice (Figures
2A and 2B). T cell expansion in RIP-Cre mice was equivalent to
that in WT mice, revealing a lack of pre-established Cre-specific
tolerancewhenCre expression was restricted to the pancreas. In
contrast, T cell expansion in CC10-Cre and Vil-Cre mice was
markedly lower than that in WT mice despite the similar
frequencies of precursor cells in all these mice. Overall, there
was no correlation between Cre:I-Ab-specific precursor and
expanded T cell numbers among our panel of mice (Figure 2C),
indicating that Cre:I-Ab-specific T cell tolerance was not a result
of T cell deletion.
Previous studies have shown that thymic negative selection of
T cells preferentially affects clones with the highest avidity TCRs
(Moon et al., 2011; Zehn and Bevan, 2006). Analysis of Cre:I-Ab
tetramer staining intensity, which provided a rough measure ofmmunity 43, 896–908, November 17, 2015 ª2015 Elsevier Inc. 897
Figure 1. Tissue-Restricted Self Antigen-
Specific CD4+ T Cells Are Not Deleted
(A) Quantitative RT-PCR data depictingCremRNA
expression levels normalized to Gapdh in indi-
cated tissues of indicated mice. Mean values ±
SEM of samples taken from at least two inde-
pendent experiments are shown.
(B) Representative flow cytometry of CD4+ single
positive thymocytes following Cre:I-Ab tetramer-
based cell enrichment of thymi.
(C) Representative flow cytometry of peripheral
CD4+ T cells following Cre:I-Ab tetramer-based
cell enrichment of pooled spleen and lymph
nodes. Plots represent Dump(B220, CD11b,
CD11c, F4/80)CD3+CD4+ events as described in
Figure S1E. Numbers above gates indicate total
numbers of Cre:I-Ab-specific CD4+ T cells calcu-
lated for the whole mouse.
(D and E) Quantitative summaries of Cre:I-Ab-
specific CD4+ (D) thymocyte or (E) peripheral T cell
numbers per mouse. Each data point repre-
sents an individual mouse. Mean values ± SEM
are shown. Dotted lines represent the limit of
detection as defined by the mean frequency of
CD8+tetramer+ events. ns, not significant, ***p <
0.001, ****p < 0.0001 for unpaired t tests between
WT and each Cre mouse. See also Figure S1.Cre:I-Ab-specific TCR avidity, did not reveal differences in TCR
avidity for any of the Cre transgenic mice except UBC-CreER
(Figures 2D and 2E), nor were there any differences in overall
TCR expression levels as evidenced by CD3 staining (Figure S2).
Overall, there was no correlation between tetramer staining
intensity and the extent of T cell expansion among the mice
(Figure 2F), indicating that the impaired responsiveness of Cre
self-antigen-specific T cells in CC10-Cre and Vil-Cre mice was
not the result of developmental selection against high avidity
T cell clones.
The tolerance of Cre:I-Ab-specific T cells was further evi-
denced by our analysis of CD4+ T cell effector functions. While
30%–35% of the Cre:I-Ab-specific T cells in WT or RIP-Cre
mice expressed IL-17 upon in vitro restimulation with PMA plus
ionomycin, only 5%–15% of these cells did so in CC10-Cre,
Vil-Cre, and UBC-CreER mice (Figures 3A and 3B). Analysis of
other cytokines did not reveal a diversion into alternative Th sub-
sets (Figure S3). Expression of the chemokine receptor CXCR5,
which enables T cells to migrate to lymph node B cell zones898 Immunity 43, 896–908, November 17, 2015 ª2015 Elsevier Inc.(Crotty, 2011), occurred in a subset
of Cre:I-Ab-specific T cells distinct from
those producing IL-17 (Figure 3C). While
the proportion of cells expressing
CXCR5 was similar in all of the mice in
our panel (Figures 3D and 3E), the devel-
opment of Cre:I-Ab-specific germinal
center follicular helper T cells (GC-
Tfh), as defined by the subset of PD-1+
CXCR5+ T cells expressing the highest
levels of these markers (Crotty, 2011),
was strikingly impaired in CC10-Cre,
Vil-Cre, and UBC-CreER mice, but not
RIP-Cre mice (Figures 3D and 3F). Thus,the reduced proliferative potential of tolerant Cre self-antigen-
specific T cells was paralleled by functional defects in cytokine
production and GC-Tfh development.
Treg Cell-Mediated Tolerance to Lung and Intestinal
Self Antigens
It was possible that steady-state presentation of Cre self antigen
resulted in the development of Cre:I-Ab-specific T cell popula-
tions that are intrinsically hyporesponsive to Cre stimulation,
perhaps through the induction of anergy or development into
Tregs. Alternatively, the nonresponsiveness of these cells might
have been maintained by steady-state interactions with tolero-
genic dendritic cells presenting Cre antigen. To determine the
role that the Cre antigen expressing environment plays in the
tolerance of Cre:I-Ab-specific T cells, we transferred whole
repertoires of purified CD4+ T cells from WT or Cre-expressing
mice into congenic host mice lacking Cre expression. Smarta
TCR transgenic mice were chosen as hosts because they lack
endogenous T cell specificity to Cre, yet provide a lymphoreplete
Figure 2. Lung and Intestinal Self Antigen-
Specific CD4+ T Cells Exhibit Impaired
Proliferative Responses
Mice were immunized with Cre peptide + CFA and
analyzed 7 days later.
(A) Representative flow cytometry of CD4+ T cells
following Cre:I-Ab tetramer-based cell enrichment
of pooled spleen and lymph nodes. Plots repre-
sent Dump(B220, CD11b, CD11c, F4/80)CD3+
CD4+ events. Numbers inside gates indicate total
numbers of Cre:I-Ab-specific CD4+ T cells calcu-
lated for the whole mouse.
(B) Quantitative summary of total Cre:I-Ab-specific
T cell numbers per mouse with fold expansion
values indicated. The dotted line represents the
limit of detection.
(C) Linear regression analysis of Cre:I-Ab-specific
T cell numbers before and after immunization for
each mouse strain. SEM, r2, and p values are
indicated.
(D) Tetramer mean fluorescence intensity (MFI),
expressed in arbitrary units, of Cre:I-Ab-specific
T cells from individual WT and Cre mice. Lines
connect mice analyzed within the same experi-
ment.
(E) Quantitative summary of tetramer MFI from
individual mice normalized to WT controls
analyzed within the same experiment.
(F) Linear regression analysis of Cre:I-Ab tetramer
staining intensity and Cre:I-Ab-specific T cell
expansion for each mouse strain. SEM, r2, and
p values are indicated.
(B and E) Mean values ± SEM are shown. ns not
significant, *p < 0.05, **p < 0.01, ***p < 0.001 for
unpaired t tests betweenWT and eachCremouse.
See also Figure S2.environment that limits donor T cell activation from homeostatic
proliferation (Sprent and Surh, 2011). As shown in Figure S4A,
Cre:I-Ab-specific T cells transferred from CC10-Cre or Vil-Cre
mice into Cre antigen-free Smarta mice were still impaired in
their ability to expand following immunization, demonstrating
that tolerancewas intrinsic to them at either the cell or population
level.
In light of these results, an attractive hypothesis was that many
of the Cre:I-Ab-specific T cells in our Cre transgenic mice were
Tregs. We have previously shown that Foxp3+ Treg subsets
are a general feature of all antigen-specific CD4+ T cell popula-
tions, and the frequency of these cells was elevated in a popula-
tion specific for a ubiquitously expressed self antigen (Moon
et al., 2011). Using a Foxp3EGFP reporter gene that was bred
into all of our mouse strains (Haribhai et al., 2007), we foundImmunity 43, 896–908, Nthat 15% of the Cre:I-Ab-specific
CD4+ T cells in the peripheral lymphoid
organs ofWTmice expressed Foxp3 (Fig-
ures 4A and 4B). This proportion was
similar in RIP-Cre mice, but elevated
to 27% and 22% in CC10-Cre and
Vil-Cre mice, respectively, which corre-
lated with their immune tolerance to
Cre. Examination of total Foxp3+ and
Foxp3 Cre:I-Ab-specific T cell numbers
in each mouse revealed that the greater representation of Tregs
did not come at the expense of Tconv cells (Figure 4C), albeit the
elevated numbers of Tregs was too small to significantly alter the
size of the total Cre:I-Ab-specific T cell population (Figure 1E).
During immunization, Cre-specific Tregs proliferated along with
their conventional counterparts in all mice, but their representa-
tion was still only elevated inCC10-Cre and Vil-Cremice (Figures
S4B–S4E).
To test the role of Tregs in Cre-specific tolerance, Cre trans-
genic mice were crossed to Foxp3-DEREGmice, which enabled
systemic ablation of Foxp3+ Tregs upon administration of diph-
theria toxin (DT) (Lahl et al., 2007). Treg ablation during Cre
immunization of CC10-Cre and Vil-Cre mice resulted in partial
restoration of Cre:I-Ab-specific T cell expansion and complete
restoration of IL-17 production (Figures 4D and 4E). In contrast,ovember 17, 2015 ª2015 Elsevier Inc. 899
Figure 3. Lung and Intestinal Self Antigen-
Specific CD4+ T Cells Exhibit Impaired
Effector Functions
Mice were immunized with Cre peptide + CFA and
analyzed 7 days later.
(A) Representative intracellular flow cytometry of
IL-17 and IFN-g cytokine expression by Cre:I-Ab-
specific CD4+ T cells from pooled spleen and
lymph nodes following in vitro restimulation with
PMA + ionomycin. Numbers indicate proportions
of cells in each quadrant.
(B) Quantitative summary of the proportion of
Cre:I-Ab-specific T cells expressing IL-17 in each
mouse.
(C) Representative flow cytometry of IL-17 and
CXCR5 expression by Cre:I-Ab-specific CD4+
T cells from a WT mouse.
(D) Representative flow cytometry of PD-1 and
CXCR5 expression by Cre:I-Ab-specific CD4+
T cells. Numbers indicate proportions of cells in
each gate.
(E and F) Quantitative summaries of proportions of
Cre:I-Ab-specific T cells exhibiting (E) CXCR5+ or
(F) PD-1hiCXCR5hi GC-Tfh cell phenotypes.
(B, E, and F) Mean values ± SEM are shown.
ns, not significant, **p < 0.01, ***p < 0.001, ****p <
0.0001 for unpaired t tests between WT and each
Cre mouse. See also Figure S3.Treg ablation did not restore these functions in UBC-CreER
mice, where tolerance was mediated by deletion. To test
whether Tregs were sufficient in mediating Cre-specific toler-
ance, we transferred purified populations of total CD4+CD25+
Tregs from WT or Cre transgenic mice into congenically marked
WT mice before immunizing them with Cre (Figure 4F). Trans-
ferred Tregs from CC10-Cre and Vil-Cre mice, but not WT,
RIP-Cre, or UBC-CreERmice, potently suppressed proliferation
of host Cre:I-Ab-specific T cells. Therefore, Cre self-antigen-spe-
cific Tregs from these mice were necessary and sufficient to
mediate Cre-specific tolerance.
Peripheral Expansion of Thymically Derived Treg Cells
The majority of Foxp3+ Tregs are either derived directly from
thymic development (tTreg) or are induced from CD4+ Tconv
cells in the periphery (pTreg) (Abbas et al., 2013; Josefowicz900 Immunity 43, 896–908, November 17, 2015 ª2015 Elsevier Inc.et al., 2012). Cre:I-Ab-specific Foxp3+
Tregs in our mice uniformly expressed
both Helios and Neuropilin-1, which was
consistent with a tTreg phenotype (Fig-
ure S5A) (Thornton et al., 2010; Yadav
et al., 2012). However, CC10-Cre and
Vil-Cre mice did not contain higher fre-
quencies of Foxp3+ Cre:I-Ab-specific thy-
mocytes, suggesting that thymic Treg
development was not enhanced in these
mice (Figure 5A). To better investigate
their origin, we utilized the Foxp3DCNS1
mouse model in which peripheral induc-
tion of pTregs is impaired due to the dele-
tion of CNS1, a critical TGF-b-responsive
regulatory region in the Foxp3 locus(Zheng et al., 2010). Irradiated WT or Vil-Cremice were reconsti-
tuted with congenic WT or Foxp3DCNS1 bone marrow, and the
extent of Cre:I-Ab-specific Foxp3+ Treg development in the re-
sulting chimeric animals was assessed. As shown in Figure 5B,
the proportion of Cre:I-Ab-specific T cells expressing Foxp3 in
Vil-Cre host mice was not affected by the absence of Foxp3-
CNS1, indicating that these cells were not pTregs, but rather
tTregs. Moreover, Vil-Cre mice reconstituted with Foxp3DCNS1
bone marrow still exhibited impaired Cre:I-Ab-specific T cell
expansion upon immunization, indicating that pTregs in general
were dispensable for Cre-specific tolerance (Figure S5B).
The tTregphenotypeofCre:I-Ab-specific Tregs inourmice sug-
gested that their developmentmight be driven by ectopic Cre an-
tigen expression in the thymus, possibly via the transcriptional
regulator Aire, which has been shown to be required for Treg
development to some, but not all, self antigens (Aschenbrenner
Figure 4. Tolerance to Lung and Intestinal Self Antigen Requires Antigen-Specific Tregs
(A) Representative flow cytometry depicting Foxp3EGFP reporter expression in CD4+ T cells following Cre:I-Ab tetramer-based cell enrichment of pooled spleen
and lymph nodes from indicated naive mice. Numbers indicate proportions of tetramer+ cells expressing Foxp3.
(B) Quantitative summary of the proportion of Cre:I-Ab-specific CD4+ T cells expressing Foxp3 in each indicated mouse strain.
(C) Quantitative summary of the total numbers of Foxp3+ and Foxp3 Cre:I-Ab-specific T cells in each indicated mouse strain.
(D) Total Cre:I-Ab-specific T cell numbers and (E) proportions of IL-17+ Cre:I-Ab-specific T cells in indicated Foxp3-DEREGmice 7 days following peptide + CFA
immunization with (closed symbols) or without (open symbols) concurrent Treg ablation by DT treatment.
(F) WT host Cre:I-Ab-specific T cell numbers 7 days after adoptive transfer of 43 106 CD4+CD25+ Tregs from indicated donor mice followed by immunization
with Cre peptide + CFA.
(B–F) Mean values ± SEM are shown. ns, not significant, *p < 0.05, **p < 0.01, ****p < 0.0001 for unpaired t tests between WT and each Cre mouse. See also
Figure S4.et al., 2007; Malchow et al., 2013; Perry et al., 2014). However,
crossing Vil-Cre mice onto an Aire-deficient background did not
alter the development of Cre:I-Ab-specific Tregs (Figure 5C) or
their ability to induce tolerance (Figure S5C), arguing against a
role for Aire in our experimental system. In addition, Batf3-depen-
dent CD8a+ dendritic cells, which have been shown to help
mediate presentation of Aire-regulated genes to developing thy-
mocytes (Perry et al., 2014), were also dispensable for Cre:I-Ab-
specific Treg development and tolerance, as shown by our use
of Batf3-deficient mice (Figures 5D and S5D). Although we did
not detect Cre mRNA in whole thymus preps (Figure 1A), we per-
formed RT-PCR analysis on flow-sorted thymic epithelial cells
(TECs) to improve sensitivity to the point where we could reliablyIdetect expression of Ins2, a known Aire-regulated gene (Ander-
son et al., 2002) (Figure 5E). While Cre mRNA expression was
readily detected in TECs fromUBC-CreERmice, it was undetect-
able in WT or any of the other Cre transgenic mice. Therefore,
the elevated levels of Cre:I-Ab-specific tTregs in CC10-Cre and
Vil-Cre mice were unlikely to be the result of thymic Cre antigen
presentation.
Tonic TCR signaling has been implicated in the maintenance
and function of mature Tregs (Levine et al., 2014; Moran et al.,
2011; Vahl et al., 2014), so an alternative possibility was that
Cre:I-Ab-specific Tregs underwent some level of clonal expan-
sion upon antigen encounter in the periphery. In support of
this hypothesis, expression analysis of the cellular proliferationmmunity 43, 896–908, November 17, 2015 ª2015 Elsevier Inc. 901
Figure 5. Tissue-Restricted Self Antigen-Specific Tregs Are Thymically Derived and Peripherally Expanded
(A) Quantitative summary of the proportion of Cre:I-Ab-specific CD4+ SP thymocytes expressing Foxp3 in each indicated mouse strain.
(B) Proportions of Cre:I-Ab-specific CD4+ T cells expressing Foxp3 in pooled spleen and lymph nodes from lethally irradiated WT or Foxp3DCNS1 mice recon-
stituted with WT or Foxp3DCNS1 bone marrow.
(C) Proportions of Cre:I-Ab-specific T cells expressing Foxp3 in pooled spleen and lymph nodes from Aire/ mice.
(D) Proportions of Cre:I-Ab-specific T cells expressing Foxp3 in pooled spleen and lymph nodes from Batf3/ mice.
(E) Quantitative RT-PCR analysis of Ins2 and CremRNA expression relative to B2m in flow sorted thymic epithelial cells (TECs). Mean values ± SEM of samples
taken from at least two independent experiments are shown.
(F) Proportions of Foxp3- (open symbols) or Foxp3+ (filled symbols) Cre:I-Ab-specific T cells expressing Ki67 in indicated mice.
(A–D, F) Mean values ± SEM are shown. ns not significant, *p < 0.05, **p < 0.01, ***p < 0.001 for unpaired t tests between WT and each Cre mouse. See also
Figure S5.marker Ki-67 revealed more steady-state cell-cycle activity
within the Cre:I-Ab-specific Foxp3+ Tregs of CC10-Cre, Vil-Cre,
and UBC-CreER mice than WT or RIP-Cre mice (Figures 5F
and S5E). Notably, the Cre:I-Ab-specific Foxp3- T cells of these
mice did not express higher levels of Ki-67, suggesting that
only Cre:I-Ab-specific Tregs and not Tconv cells were prolifer-
ating in response to Cre self antigen.
Limited Durability of Steady-State Treg Cell-Mediated
Tolerance
Tregs have been shown to establish immune memory (Rose-
nblum et al., 2011), so we asked whether Cre-specific tolerance
in CC10-Cre and Vil-Cremice would be enhanced or diminished
upon successive immune challenges. Cre peptide emulsified in
CFA is not efficiently cleared after injection, thereby complicating
interpretations of immune memory. Therefore, we utilized the
bacterium Listeria monocytogenes, which is quickly cleared after
infection, as an alternative antigen delivery system to induce
acuteprimaryCre-specificTcell responses (Pamer, 2004).We in-
fected mice systemically with a recombinant strain of Listeria
(Lm-Cre) expressingCre61-71 peptide embedded in chicken oval-
bumin (OVA). This resulted in Cre:I-Ab-specific T cell expansion
and GC-Tfh cell development that mirrored the patterns of toler-
ance seen with peptide immunization (Figures S6A, S6C, and
S6E). Notably, T cell responses to the endogenous Listeria Lister-902 Immunity 43, 896–908, November 17, 2015 ª2015 Elsevier Inc.iolysin O (LLO) antigen were equivalent in all mice (Figures S6B,
S6D, and S6F), indicating that a single Cre:I-Ab epitope-specific
population of Tregs was insufficient to mediate bystander sup-
pression of other Listeria antigen-specific T cell responses.
Lm-Cre infectedmice were given 4 weeks to recover and were
then rechallengedwith Cre peptide + CFA (Figure 6A). In contrast
to the primary immune response, Cre:I-Ab-specific T cells in
rechallenged CC10-Cre and Vil-Cre mice now exhibited robust
expansion, cytokine production (IL-17 and IFN-g), and GC-Tfh
development that was equivalent to WT controls (Figures 6A,
6B, 6D, 6E, S6G, and S6H). Moreover, the expansion of
Cre:I-Ab-specific T cells now correlated directly with the number
of Cre:I-Ab-specific precursors before secondary challenge (Fig-
ure 6C), indicating a loss of nondeletional tolerance. In contrast,
Cre:I-Ab-specific T cells in UBC-CreER mice remained unre-
sponsive as before, demonstrating the greater durability of dele-
tional tolerance.
The loss of tolerance and expansion of Cre:I-Ab-specific T cells
also resulted in their influx into thepancreas, lungs, and intestines
(Figure 6F and S6I). Notably, the extent of Cre:I-Ab-specific T cell
accumulation was greater in tissues expressing Cre, concordant
with a role for antigen recognition in T cellmigration or retention in
nonlymphoid tissues (Figure 6G). Although Cre:I-Ab-specific
Foxp3+ Tregs were not observed in any of these tissues (data
not shown), none of these mice exhibited obvious signs of
Figure 6. Treg Mediated Tolerance to Tissue-Restricted Self Antigens Is Lost upon Secondary Immune Challenge
(A) Mice were infected with Lm-Cre, and 4 weeks later rechallenged with Cre peptide + CFA. Total Cre:I-Ab-specific T cell numbers in pooled spleen and lymph
nodes for each mouse strain are shown at each time point. Mean values ± SEM are indicated.
(B) Quantitative summary of total Cre:I-Ab-specific T cell numbers in pooled spleen and lymph nodes before and after secondary challenge with fold expansion
values indicated. The dotted line represents the limit of detection.
(C) Linear regression analysis of Cre:I-Ab-specific T cell numbers before and after secondary immune challenge. SEM, r2, and p values are indicated.
(legend continued on next page)
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autoimmunity with the exception of RIP-Cremice, which experi-
enced a slight and transient increase in blood glucose levels (Fig-
ure 6H and data not shown). Therefore, breaking tolerance to a
single self-antigen epitope resulted in strong epitope-specific
effector T cell functions, but this was not enough to initiate sus-
tained autoimmunity.
To investigate the mechanism by which Cre:I-Ab-specific
tolerance was lost in CC10-Cre and Vil-Cre mice, we compared
Cre:I-Ab-specific Treg populations present in these mice just
before primary and secondary immunizations. Both the propor-
tions and numbers of Tregs within the Cre:I-Ab-specific T cell
population analyzed just before secondary challenge (Figures
7A and 7B) were substantially reduced from that prior to primary
immunization (Figure 4B). Furthermore, when purified popula-
tions of total CD4+CD25+ Tregs were transferred from these
mice into WT recipients, host T cell responses to peptide +
CFA immunization were no longer suppressed as before (Figures
7C and 4F). Collectively, these results indicate that the loss of
tolerance after immunization was the result of a new equilibrium
established between Cre:I-Ab-specific Treg and Tconv subsets.
DISCUSSION
By studying an endogenous CD4+ T cell population with speci-
ficity for a single epitope of a self antigen expressed under
different tissue-restricted patterns, we have provided direct evi-
dence that deletional T cell tolerance is minimal to nonexistent
for some tissue-restricted self antigens. Rather, mature T cell
populations with specificity to such self antigens may be largely
ignorant, aswe observed in the case of pancreatic expression, or
might develop steady-state tolerance through enhanced anti-
gen-specific Treg activity, as observed in the case of lung and in-
testinal expression. These findings support the concept that
T cell tolerance to some tissue-restricted self antigens are
shaped entirely by nondeletional processes outside the thymus.
Our conclusion that Cre-specific T cells do not undergo dele-
tion in tissue-restricted Cre-expressing mice is based on our
direct measurements of endogenous antigen-specific T cell fre-
quencies in both the thymic and peripheral T cell compartments
ofWT andCre-expressingmice. Our findings are congruous with
recent tetramer-based studies by Davis and colleagues showing
that the frequencies of several self-antigen-specific T cell popu-
lations in humans are in the same range as frequencies for
foreign antigen-specific populations (Su et al., 2013; Yu et al.,
2015). While it is formally possible that the presence of Cre anti-
gen caused the deletion of some Cre-specific T cell clones while
promoting the development of others, resulting in no net change
in frequency, our data show that any such changes in the Cre-
specific T cell repertoire did not result in notable differences in(D and E) Proportions of Cre:I-Ab-specific T cells (D) expressing IL-17 or IFN-g cy
challenge.
(F) Cre:I-Ab-specific T cell numbers in the pancreas, lungs, and intestines of ind
represent the limit of detection.
(G) Cre:I-Ab-specific T cell numbers in indicated tissues after secondary immuniza
mouse.
(H) Blood glucose levels in naive WT or RIP-Cre mice 7–10 days after primary or
(B, D–H) Mean values ± SEM are shown. ns, not significant, *p < 0.05, **p < 0.01,
indicated conditions. See also Figure S6.
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numbers of Foxp3+ Cre-specific T cells in CC10-Cre and Vil-
Cremice were not offset by lower numbers of Foxp3 cells, sug-
gesting that Tconv cells were not being diverted into a Treg fate
in the thymi of these mice.
Our results contrast with our previous findings of robust nega-
tive selection against T cells specific for ubiquitously expressed
self antigens (Moon et al., 2011), upholding the general assump-
tion that tissue-restricted self antigens elicit less efficient dele-
tional tolerance. The complete absence of T cell deletion in our
current study also contrasts with a previous report demon-
strating that about 25% of a single chain TCR transgenic CD8+
T cell population with specificity to a pancreas-restricted OVA
model self antigen are deleted (Zehn and Bevan, 2006). How-
ever, OVA is expressed in the thymi of the RIP-mOVA mice
used in this study (Gallegos and Bevan, 2004), while we could
not detect any thymic expression of Cre in RIP-Cre mice. It is
possible that the discrepancy in thymic expression is due to
the small size of the RIP2 promoter used in these mice, which
might be influenced by local chromatin effects unique to each
transgene insertion site.
Interestingly, theCC10 and villin genes are both Aire-regulated
(M. Anderson, personal communication) and expressed in med-
ullary thymic epithelial cells (Derbinski et al., 2005). However, we
did not detect thymic expression of Cre in either CC10-Cre and
Vil-Cre mice, suggesting that Aire-mediated regulation of trans-
genic promoters might not accurately reflect that of their corre-
sponding endogenous promoters. Our findings therefore might
not be directly applicable to these endogenous self antigens or
others that are regulated by Aire. However, it is unclear whether
all tissue-restricted genes are ectopically expressed in the
thymus through the function of Aire or other mechanisms, and
whether such expression always results in physiological antigen
presentation to thymocytes. Our colleagues previously showed
that in the case of the eye-restricted protein IRBP, thymic
expression through Aire results in the tolerance of T cells specific
for only some of the epitopeswithin this protein, and this is due to
differences in the efficiency by which these epitopes are pre-
sented (Taniguchi et al., 2012). Thus, it is likely that a large num-
ber of epitopes in tissue-restricted self antigens are not routinely
detected by developing thymocytes. Moreover, neo-epitopes
created by genetic mutations in tumor cells would represent
another class of self epitopes unrepresented during thymic se-
lection. Our findings reveal the relevant potential outcomes of
T cell development and tolerance to those self antigens that
are not thymically expressed or presented.
The lack of deletion in RIP-Cre mice resulted in an apparent
complete lack of tolerance to the Cre epitope, as Cre-specific
T cells in these mice responded to antigen stimulation just astokines, or (E) exhibiting a GC-Tfh phenotype 7 days after secondary immune
icated mice 7–9 days after primary or secondary immunization. Dotted lines
tion, expressed as a percentage of total Cre:I-Ab-specific T cells from thewhole
secondary immunization.
***p < 0.001 for unpaired t tests between WT and each Cremouse or between
Figure 7. The Balance between Treg and Tconv Is Altered after Immune Challenge
Mice were infected with Lm-Cre and Cre:I-Ab-specific Tregs from the pooled spleen and lymph nodes were analyzed 4 weeks later.
(A) Proportions of Cre:I-Ab-specific T cells expressing Foxp3.
(B) Cre:I-Ab-specific T cell numbers in indicated mice.
(C) WT host Cre:I-Ab-specific T cell numbers 7 days after adoptive transfer of 43 106 CD4+CD25+ Tregs from indicated donor mice followed by immunization
with Cre peptide + CFA.
(A–C) Mean values ± SEM are shown. ns, not significant, *p < 0.05, **p < 0.01 for unpaired t tests between WT and each Cre mouse.well as those in WT mice. Our data suggest that RIP2-driven
Cre expression in the pancreas normally results in a level of
Cre:I-Ab presentation that is insufficient to activate Cre-specific
T cells under steady-state non-inflammatory conditions. How-
ever, after two rounds of immunization, Cre-specific T cells
accumulated in the pancreas of RIP-Cre mice and these mice
experienced elevated blood glucose levels, suggesting that
inflammatory conditions can enhance presentation of this self
antigen to a level where it is readily detectable by antigen-spe-
cific T cells.
Cre-specific T cells were also spared from deletion in CC10-
Cre and Vil-Cre mice, but tolerance to Cre was established by
Cre-specific Foxp3+ Tregs that were present at elevated fre-
quencies. Our data indicate that these Tregs were most likely
derived from the thymus rather than induced from Cre-specific
Tconv cells, which is consistent with the general belief that
tTregs are predominantly specific for self antigens (Hsieh
et al., 2012; Josefowicz et al., 2012). However, because we
did not detect any thymic Cre expression or elevated fre-
quencies of Cre-specific Foxp3+ thymocytes in these mice,
we believe that the elevated frequency of Cre-specific Tregs
was not the result of increased tTreg output from the thymus,
but rather the expansion of these cells in the periphery after an-
tigen encounter. This model is supported by the elevated level
of cell cycle activity we found in these cells, and is consistent
with studies indicating that Tregs experience more steady-state
TCR signaling than Tconv cells (Fisson et al., 2003; Moran
et al., 2011), which supports their persistence in the periphery
(Levine et al., 2014; Vahl et al., 2014). In our study, only Cre-
specific Treg and not Tconv cells exhibited increased cell-cycle
activity, suggesting that they are more responsive to self anti-
gens. It is also possible that Tconv cells are also sensing self
antigen, but are continuously suppressed by their Treg counter-
parts, as suggested by recent studies of human self antigen-
specific CD8+ T cells (Maeda et al., 2014).
Treg-mediated tolerance to Cre in CC10-Cre and Vil-Cre
mice was functionally equivalent to deletional tolerance in
UBC-CreER mice during primary immune responses, but dur-
ing a secondary immune challenge, this tolerance was lostIwhile deletional tolerance in UBC-CreER mice remained intact.
Our data indicated that the balance of Cre-specific Treg and
Tconv cells was altered such that tolerance was no longer a
favorable outcome upon secondary challenge. However, it is
also possible that the memory Tconv cells stimulated during
the secondary antigen challenge were less susceptible to
Treg-mediated suppression than their naive precursors. These
results contrast with the suppressive Treg memory established
in another self-antigen-specific T cell study (Rosenblum et al.,
2011). However, this earlier study involved sterile expression
of self antigen through a drug-inducible promoter, whereas
our study involved antigen challenges in the presence of strong
microbial adjuvants. Thus, self-antigen-specific T cell memory
might be influenced by qualitative features of the priming auto-
immune response.
Despite the loss of Treg tolerance, Cre-specific T cell
numbers contracted over time and, with the exception of
some mild hyperglycemia in RIP-Cre mice, there were no signs
of autoimmunity in our mice. While strong T cell responses
against this single epitope might have initiated some damage
to Cre-expressing tissue, it is likely that Tregs specific for other
epitopes within Cre, as well as the many other self antigens
within the tissue environment, would have provided ample
bystander suppression to eventually subdue the response.
Conversely, during infection of Cre-expressing mice with Cre
peptide-expressing Listeria, the single Cre epitope-specific
Treg population was unable to suppress T cell responses to im-
munodominant epitopes from the bacteria. Thus, the breadth of
steady-state Treg tolerance to several self antigens in a tissue
likely supports a level of robustness that resists the develop-
ment of autoimmunity from isolated immune responses to one
or a few self antigen epitopes.
Our results indicate that self-antigen-specific Tregs constitute
a less durable, yet more flexible, form of tolerance than T cell
deletion. A consequence of this flexibility would be the immune
system’s ability to recruit these self-antigen-specific T cells
against crossreactive antigens expressed by pathogens or tu-
mors. The establishment of Treg-mediated tolerance to the large
numbers of tissue-restricted self antigens in the body wouldmmunity 43, 896–908, November 17, 2015 ª2015 Elsevier Inc. 905
allow the immune system to retain a more diverse repertoire of
TCR specificities than would be possible through deletional
tolerance alone. While this could be beneficial for antimicrobial
and antitumor immunity, it might come at a cost of higher risks
for autoimmunity.
The different levels of T cell tolerance established to different
tissue-restricted self antigens are likely attributable to the quan-
tity andquality of self antigenpresentation in the respective tissue
environments. The lung and intestines are much larger than the
pancreas, and moreover, they contain mucosal surfaces from
which foreign antigens are continually sampled. As we observed
in our panel of Cre mice, presentation of self antigens to circu-
lating T cells might be more efficient in these types of tissues,
enabling the antigen recognition that sustains self-antigen-spe-
cific Tregs. It is also possible that the dendritic cell subsets drain-
ing these tissues might be more supportive for the development
andmaintenanceof Tregs. Thepaucity of steady-state Treg toler-
ance to self antigens in organs like the pancreas might result in
a greater vulnerability to the aberrant initiation of autoimmune
responses, which we speculate could be an underlying factor
for the high prevalence of autoimmune diseases in these organs.
The enhancement of autoantigen-specific Treg activity is a
popular focus for autoimmune disease therapies. The feasibility
of this strategy is supported by our discovery that antigen-spe-
cific Treg activity constitutes a normal steady-state mechanism
of tolerance for some tissue-restricted self antigens. From
another standpoint, the lack of deletional tolerance and limited
durability of Treg-mediated tolerance to tissue-restricted self an-
tigens offers a strong rationale for the development of cancer
vaccines targeting tissue-restricted tumor antigens.
EXPERIMENTAL PROCEDURES
Mice
References for mouse strains can be found in Supplemental Experimental
Procedures. For all experiments, spleen and lymph nodes were harvested
from 5- to 8-week-old mice (except for long-term immunization studies), and
thymuses were harvested from 5- to 6-week-old mice. All animal experiments
were conducted according to federal and institutional guidelines under
approved Institutional Animal Care and Use Committee protocols.
Immunizations and Infections
All peptides were custom ordered from Genscript. For peptide immunizations,
micewere injected subcutaneously at the base of the tail with 100 mg peptide in
50 ml of a 1:1 emulsion of PBS and complete Freund’s adjuvant (Sigma).DactA
Listeria monocytogenes expressing the Cre epitope (Lm-Cre) was generated
as previously described (Orr et al., 2007). Mice were infected intravenously
at a dose of 108 CFU. For Treg ablation experiments, Foxp3-DEREG mice
were injected intraperitoneally with 75 mg/kg diphtheria toxin (List Biologicals)
at days 1 and 2 post antigen immunization.
Tetramer-Based Cell Enrichment and Flow Cytometry
Single cell suspensions were stained with tetramer at a final concentration of
10 nM for 1 hr at room temperature, and then magnetically enriched as
described in detail (Legoux andMoon, 2012;Moon et al., 2007). For intracellular
cytokine staining, tetramer-based cell enrichment was not used. Instead, total
CD4+ T cells were isolated (Miltenyi) from draining lymph nodes of day 7 immu-
nizedmice and restimulated in vitro for 2 hr at 37Cwith 50 ng/ml PMA (Sigma),
500 ng/ml ionomycin (Sigma), and 10 mg/ml brefeldin A (Sigma). The cells were
then surface stainedwith tetramer and antibodies, washed, and then fixed, per-
meabilized, and stained for intracellular cytokines using the Cytofix/Cytoperm
kit (BD Biosciences). For Ki67 expression analysis, pooled spleen and lymph
nodecells from1 immunizedor 2–3naivemicewere fixedandpermeabilizedus-906 Immunity 43, 896–908, November 17, 2015 ª2015 Elsevier Inc.ing the Foxp3 Fixation/Permeabilization kit (eBioscience) prior to Ki67 antibody
staining. Helios stainingwas performedwith the same kit. 7-9 color flow cytom-
etry was performed on an LSRII or Fortessa (BD Immunocytometry Systems).
Data were analyzed with FlowJo software (Treestar). All antibodies were pur-
chased from BioLegend, eBioscience, BD PharMingen, or Life Technologies.
T Cell Transfers
Total CD4+ T cells from the pooled spleen and lymph nodes of WT or Cremice
were magnetically purified (Miltenyi) and 2 3 107 were transferred intrave-
nously into CD45.1 or CD45.2 congenic Smarta mice, where 3 3 106 cells
stably engrafted. For Treg transfer experiments, total CD4+ CD25+ T cells
from the pooled spleen and lymph nodes of WT or Cremice were magnetically
purified (Miltenyi) and 43 106 were transferred intravenously into CD45.1 or
CD45.2 congenic WTmice, where106 stably engrafted. Recipient mice were
then immunized the next day, and host Cre:I-Ab-specific CD4+ T cells were
isolated and analyzed 7 days later.
Irradiation Bone Marrow Chimeras
Lethally irradiated (950 rads) WT or Vil-Cre mice were reconstituted intrave-
nously with 107 bone marrow cells from CD45.1 or CD45.2 congenic WT or
Foxp3DCNS1 mice. Lymphoid tissues from the resulting chimeric mice were
harvested 7–8 weeks later for analysis of Cre:I-Ab-specific T cells.
Tissue T Cell Isolation
Spleen and lymph nodes were mashed over 100 mm nylon mesh to create
single cell suspensions. To prepare single cell suspensions from nonlymphoid
tissues, euthanized mice were first perfused with 25 ml PBS. Pancreases were
injected with 800 mg/ml collagenase P (Roche) and 40 mg/ml DNase I (Roche),
incubated 15 min at 37C, and mashed over 100 mm nylon mesh. Cells were
then centrifuged over a 44/67% Percoll gradient (GE Healthcare) to isolate
the lymphocyte-containing fraction. Lungs were incubated with 70 mg/ml
Liberase TM (Roche) and 10 mM aminoguanidine (Sigma) in HEPES buffer,
digested at 37C for 30 min, and dissociated with a gentleMACS Dissociator
(Miltenyi). Pooled Peyer’s patches, small intestine, and colon lamina proprias
were isolated using a Lamina Propria Dissociation Kit (Miltenyi) followed by a
35%/70% Percoll gradient to isolate the lymphocyte-containing fraction.
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